Abstract:Macrophages are critical regulators of the tumor microenvironment and often present an immuno-suppressive phenotype, supporting tumor growth and immune evasion. Promoting a robust pro-inflammatory macrophage phenotype has emerged as a therapeutic modality that supports tumor clearance, including through synergy with immune checkpoint therapies. Polyglucose nanoparticles (macrins), which possess high macrophage affinity, are useful vehicles for delivering drugs to macrophages, potentially altering their phenotype. Here, we examine the potential of functionalized macrins, synthesized by crosslinking carboxymethyl dextran with L- lysine, as effective carriers of immuno-stimulatory drugs to tumor-associated macrophages (TAMs). Azide groups incorporated during particle synthesis provided a handle for click-coupling of propargyl-modified β-cyclodextrin to macrins under mild conditions. Fluorescence-based competitive binding assays revealed the ability of β-cyclodextrin to non-covalently bind to hydrophobic immuno-stimulatory drug candidates (K eq ~ 10 3 M -1 ), enabling drug loading within nanoparticles. Furthermore, transcriptional profiles of macrophages indicated robust pro-inflammatory reprogramming (elevated Nos2 and Il12 ; suppressed Arg1 and Mrc1 expression levels) for a subset of these immuno-stimulatory agents (UNC2025 and R848). Loading of R848 into the modified macrins improved the drug's effect on primary murine macrophages by three-fold in vitro . Intravital microscopy in IL-12-eYFP reporter mice (24 h post-injection) revealed a two-fold enhancement in mean YFP fluorescence intensity in macrophages targeted with R848-loaded macrins, relative to vehicle controls, validating the desired pro-inflammatory reprogramming of TAMs in vivo by cell-targeted drug delivery. Finally, in an intradermal MC38 tumor model, cyclodextrin-modified macrin NPs loaded with immunostimulatory drugs significantly reduced tumor growth. Therefore, efficient and effective repolarization of tumor-associated macrophages to an M1-like phenotype—via drug-loaded macrins—inhibits tumor growth and may be useful as an adjuvant to existing immune checkpoint therapies.

Functional Polymer/inorganic Hybrid Nanoparticles for Macrophage Targeting Delivery of Oligodeoxynucleotides in Cancer Immunotherapy

Targeting Delivery of Oligodeoxynucleotides to Macrophages by Mannosylated Cationic Albumin for Immune Stimulation in Cancer Treatment.

A Dual Macrophage Targeting Nanovector for Delivery of Oligodeoxynucleotides to Overcome Cancer-Associated Immunosuppression.

Aminated yeast β-D-glucan for macrophage-targeted delivery of CpG oligodeoxynucleotides and synergistically enhanced cancer immunotherapy

Self-modifying NanoEnhancers Facilitating Lysosomal Escape for Cgas-Sting Cascading Activation in Tumor Immunotherapy

Engineering CpG‐ASO‐Pt‐loaded Macrophages (CAP@M) For Synergistic Chemo‐/Gene‐/Immuno‐Therapy

Functionalized Multi-Walled Carbon Nanotubes for Targeting Delivery of Immunostimulatory CpG Oligonucleotides Against Prostate Cancer

Yeast β-Glucan-Grafted Glycogen Nanoparticles for Macrophage-Targeted Precise Delivery of CpG Oligodeoxynucleotides: Implications for Immunotherapy Applications

Targeted Delivery of Oligonucleotides into Tumor-Associated Macrophages for Cancer Immunotherapy

Homotypic Targeting of Immunomodulatory Nanoparticles for Enhanced Peripheral and Central Immunity

Macrophage-Membrane-Coated Nanoparticles for Tumor-Targeted Chemotherapy.

Tumor microenvironment-responsive spherical nucleic acid nanoparticles for enhanced chemo-immunotherapy

Activating Macrophage‐Mediated Cancer Immunotherapy by Genetically Edited Nanoparticles

A Polyethylenimine-Modified Carboxyl-Poly(Styrene/Acrylamide) Copolymer Nanosphere for Co-Delivering of Cpg and Tgf-Beta Receptor I Inhibitor with Remarkable Additive Tumor Regression Effect Against Liver Cancer in Mice

A Multi-Functional Macrophage And Tumor Targeting Gene Delivery System For The Regulation Of Macrophage Polarity And Reversal Of Cancer Immunoresistance

Host-functionalization of macrin nanoparticles to enable drug loading and control tumor-associated macrophage phenotype

Mn2+/CpG Oligodeoxynucleotides Codecorated Black Phosphorus Nanosheet Platform for Enhanced Antitumor Potency in Multimodal Therapy

An intelligent responsive macrophage cell membrane-camouflaged mesoporous silicon nanorod drug delivery system for precise targeted therapy of tumors

Multi-functional carboxymethyl chitin-based nanoparticles for modulation of tumor-associated macrophage polarity

Ph-Responsive Core-Shell Nanogels Induce in Situ Antigen Production for Cancer Treatment

Targeting Delivery Oligonucleotide into Macrophages by Cationic Polysaccharide from Bletilla Striata Successfully Inhibited the Expression of TNF-α